Waverley Pharma Inc. (TSXV:WAVE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
At close: Apr 17, 2026

Waverley Pharma Revenue

In the year 2025, Waverley Pharma had annual revenue of 1.35M CAD with 183.90% growth. Waverley Pharma had revenue of 297.00K in the quarter ending December 31, 2025, a decrease of -34.43%.

Revenue
1.35M
Revenue Growth
+183.90%
P/S Ratio
0.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
540.00K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.35M874.23K183.90%
Dec 31, 2024475.37K63.28K15.36%
Dec 31, 2023412.09K-834.74K-66.95%
Dec 31, 20221.25M-506.02K-28.87%
Dec 31, 20211.75M377.74K27.47%
Dec 31, 20201.38M217.84K18.82%
Dec 31, 20191.16M933.87K418.02%
Dec 31, 2018223.40K--
Dec 31, 2017---
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition